<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Lin CH</submitter><pubmed_abstract>Herein, we report a case of bilateral simultaneous central retinal vein occlusion (CRVO) secondary to coronavirus disease 2019 (COVID-19). A 48-year-old man, with hypertension, type 2 diabetes mellitus, and stage 4 chronic kidney disease, diagnosed with COVID-19 1 month ago presented to the ophthalmology department with blurred vision in both eyes for 2 weeks. Ocular examination revealed a classic clinical presentation of CRVO in both eyes. Optical coherence tomography revealed increased central macular thickness with intraretinal and subretinal fluid in both eyes. Laboratory data revealed elevated D-dimer and C-reactive protein (CRP) levels. The levels of other hypercoagulability markers were normal. The patient received intravitreal anti-vascular endothelial growth factor therapy in both</pubmed_abstract><journal>Case reports in ophthalmology</journal><pagination>56-61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9938397</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Bilateral Simultaneous Central Retinal Vein Occlusion Secondary to COVID-19: A Case Report.</pubmed_title><pmcid>PMC9938397</pmcid><pubmed_authors>Sun IT</pubmed_authors><pubmed_authors>Lin CH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bilateral Simultaneous Central Retinal Vein Occlusion Secondary to COVID-19: A Case Report.</name><description>Herein, we report a case of bilateral simultaneous central retinal vein occlusion (CRVO) secondary to coronavirus disease 2019 (COVID-19). A 48-year-old man, with hypertension, type 2 diabetes mellitus, and stage 4 chronic kidney disease, diagnosed with COVID-19 1 month ago presented to the ophthalmology department with blurred vision in both eyes for 2 weeks. Ocular examination revealed a classic clinical presentation of CRVO in both eyes. Optical coherence tomography revealed increased central macular thickness with intraretinal and subretinal fluid in both eyes. Laboratory data revealed elevated D-dimer and C-reactive protein (CRP) levels. The levels of other hypercoagulability markers were normal. The patient received intravitreal anti-vascular endothelial growth factor therapy in both</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan-Dec</publication><modification>2025-04-21T15:13:39.342Z</modification><creation>2025-04-21T15:13:39.342Z</creation></dates><accession>S-EPMC9938397</accession><cross_references><pubmed>36820307</pubmed><doi>10.1159/000529298</doi></cross_references></HashMap>